AN ACT CONCERNING THE SHORTAGE OF CERTAIN DRUGS PRESCRIBED TO TREAT TYPE II DIABETES.
To provide that the Commissioner of Consumer Protection shall adopt regulations to ensure that there is a sufficient supply of dulaglutide and semaglutide to treat patients in this state who have been diagnosed with type II diabetes.
Introduced by:General Law Committee
|New today||2-4 days old||5 days & older|
|Text of Bill|
|File No. 94 [doc]|
|GL Joint Favorable [doc]|
|Committee Bill [doc]|
|Proposed Bill [doc]|
|Senate Roll Call Vote 140|
View or Add Notes to SB-80
Add Notes to SB-80
Go To My Bills
This bill is in My Bills.
Do you wish to go to My Bills?
Co-sponsors for Amendment LCO:
|5/5/2023||House Calendar Number 489|
|5/5/2023||Favorable Report, Tabled for the Calendar, House|
|3/16/2023||(LCO)||File Number 94|
|3/16/2023||Senate Calendar Number 84|
|3/16/2023||Favorable Report, Tabled for the Calendar, Senate|
|3/16/2023||(LCO)||Reported Out of Legislative Commissioners' Office|
|3/10/2023||(LCO)||Referred to Office of Legislative Research and Office of Fiscal Analysis 03/15/23 5:00 PM|
|3/3/2023||(LCO)||Filed with Legislative Commissioners' Office|
|2/28/2023||Referred to Joint Committee on General Law|
|2/27/2023||Drafted by Committee|
|2/16/2023||(GL)||Vote to Draft|
|2/3/2023||Public Hearing 02/07|
|1/19/2023||(GL)||Reserved for Subject Matter Public Hearing|
|1/12/2023||Referred to Joint Committee on General Law|